Filing Details
- Accession Number:
- 0001181431-13-024677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-02 16:06:22
- Reporting Period:
- 2013-04-30
- Filing Date:
- 2013-05-02
- Accepted Time:
- 2013-05-02 16:06:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017405 | A Nicholas Lopardo | 940 Winter Street Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-04-30 | 3,263 | $0.00 | 72,190 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2013-05-01 | 6,440 | $21.67 | 78,630 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-01 | 6,440 | $30.85 | 72,190 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | NQ Stock Option (right to buy) | Acquisiton | 2013-04-30 | 5,601 | $0.00 | 5,601 | $30.51 |
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2013-05-01 | 6,440 | $0.00 | 6,440 | $21.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,601 | 2020-04-30 | No | 4 | A | Direct | |
| 0 | 2013-05-02 | No | 4 | M | Direct |
Footnotes
- Includes shares related to dividends on shares in the Deferred Compensation Plan in the Reporting Person's account.
- This option vests in three equal annual installments beginning on the first anniversary of the date of grant, and has a 7 year exercise term.
- This option became exercisable in three equal annual installments beginning on May 2, 2007, which was the first anniversary of the date on which the option was granted.
Billionaire Hedge Funds
